United States · For profit

Bell Biosystems

Bell Biosystems, a research-stage biotechnology company, develops tools that accelerate innovations in oncology and cell therapy research.

ClosedFor profit

Berkeley, United States

Why reach out now

What the record says about Bell Biosystems as a customer or partner.

Listed as closedThe sources list it as no longer operating. Check before reaching out.

Set against every company in the directory.

Across all 5.9M companies: larger than 0% of those with a size listed; older than 40% of those with a founding year.

What it does

BiotechnologyClinical TrialsOncologyTherapeutics

What the source datasets report. We have not watched these rounds ourselves.

$9.1M

raised in total, currency not stated across 3 rounds

Last raised Apr 2015, 11 years ago

Who started it and how it trades.

Bell Biosystems filed 3 raises, $4.2M in all. Filings say how much was sold and to how many investors; they never name the investors.

Dec 2013$3.8M25 investorsequitySEC Form D
May 2012$250K3 investorsequity, debt, options, securities on exerciseof $2.0M offeredSEC Form D
Jun 2011$120K9 investorsequity, debt, options, securities on exerciseSEC Form D

Everything the source datasets list about Bell Biosystems, field by field. Contact details are held but never shown.

The company6 fields

Where3 fields

Size and reach1 field

Show 9 more fieldsShow fewer fields

Funding, as listed7 fields

About this record2 fields

Six million companies, filtered by size, age and reach, ready to export with emails on Pro.